Literature DB >> 11934669

Cr supplementation decreases tyrosine phosphorylation of the CreaT in skeletal muscle during sepsis.

Weiyang Wang1, Michael A Jobst, Brian Bell, Chun-Rui Zhao, Li-Hong Shang, Danny O Jacobs.   

Abstract

Myocellular creatine (Cr) uptake is predominantly governed by a sodium-dependent Cr transporter (CreaT) and plays a pivotal role in skeletal muscle energy metabolism. The CreaT belongs to a neurotransmitter transporter family that can be functionally regulated by protein tyrosine kinase-induced tyrosine phosphorylation. The association between myocellular Cr and c-Src-related tyrosine phosphorylation of the CreaT and the influence of oral Cr supplementation on this association were investigated during sepsis. Animals were randomized to receive standard rat chow or standard rat chow with oral Cr supplementation for 4 days followed by cecal ligation and puncture (CLP) or sham operation. Fast-twitch gastrocnemius muscles were harvested 24 h after operation. Myocellular free Cr levels were 70% higher after CLP. Western blotting of the immunoprecipitated CreaT with an anti-phosphotyrosine or anti-phospho-c-Src (Y-416) antibody revealed that tyrosine phosphorylation of the CreaT and tyrosine-phosphorylated c-Src (Tyr(416)) expression in the CreaT-c-Src complex were significantly increased after CLP compared with sham operation. These changes were observed in homogenates and plasma membrane fractions of gastrocnemius muscles. Although oral Cr supplementation increased myocellular free Cr levels equivalently in CLP and sham-operated animals, c-Src-related tyrosine phosphorylation of the CreaT in homogenates and plasma membrane fractions of gastrocnemius muscles was, however, downregulated in Cr-supplemented CLP animals compared with Cr-supplemented sham-operated rats. During sepsis, increased myocellular free Cr levels are associated with enhanced tyrosine phosphorylation of the CreaT, which is likely induced by active c-Src. Oral Cr supplementation downregulates c-Src-related tyrosine phosphorylation of the CreaT. The data suggest that myocellular Cr homeostasis and CreaT activity are tightly regulated and closely related during sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934669     DOI: 10.1152/ajpendo.00506.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  5 in total

1.  Downregulation of the creatine transporter SLC6A8 by JAK2.

Authors:  Manzar Shojaiefard; Zohreh Hosseinzadeh; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2012-03-11       Impact factor: 1.843

2.  Creatine transporters: a reappraisal.

Authors:  Oliver Speer; Lukas J Neukomm; Robyn M Murphy; Elsa Zanolla; Uwe Schlattner; Hugues Henry; Rodney J Snow; Theo Wallimann
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 3.  Augmentation of Creatine in the Heart.

Authors:  Sevasti Zervou; Hannah J Whittington; Angela J Russell; Craig A Lygate
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

4.  A role for thioredoxin-interacting protein (Txnip) in cellular creatine homeostasis.

Authors:  Sevasti Zervou; Tanmoy Ray; Natasha Sahgal; Liam Sebag-Montefiore; Rebecca Cross; Debra J Medway; Philip J Ostrowski; Stefan Neubauer; Craig A Lygate
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-28       Impact factor: 4.310

5.  The regulation and expression of the creatine transporter: a brief review of creatine supplementation in humans and animals.

Authors:  Ryan D Schoch; Darryn Willoughby; Mike Greenwood
Journal:  J Int Soc Sports Nutr       Date:  2006-06-23       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.